5-methoxyluzindole has been researched along with 4-phenyl-2-propionamidotetraline in 2 studies
| Studies (5-methoxyluzindole) | Trials (5-methoxyluzindole) | Recent Studies (post-2010) (5-methoxyluzindole) | Studies (4-phenyl-2-propionamidotetraline) | Trials (4-phenyl-2-propionamidotetraline) | Recent Studies (post-2010) (4-phenyl-2-propionamidotetraline) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 72 | 1 | 29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubocovich, ML; Iacob, S; Masana, MI; Sauri, DM | 1 |
| Cecon, E; Jockers, R; Rivara, S; Witt-Enderby, PA; Zlotos, DP | 1 |
2 other study(ies) available for 5-methoxyluzindole and 4-phenyl-2-propionamidotetraline
| Article | Year |
|---|---|
Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.
Topics: Animals; Cell Line; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Melatonin; Rabbits; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Receptors, Presynaptic; Recombinant Proteins; Retina | 1997 |
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
Topics: Animals; Binding Sites; Depressive Disorder; Humans; Ligands; Melatonin; Models, Molecular; Protein Multimerization; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship | 2014 |